Assessing the recipient and donor
Transplantation places a functioning donor kidney in a person with kidney failure. Assessment covers medical fitness, blood group and compatibility, infection screening, anatomy and the overall transplant plan.
A living donor undergoes a separate evaluation, with attention to long-term health and informed consent. Availability of a willing donor alone does not establish eligibility.
The surgical approach
In a typical transplant, the donor kidney’s blood vessels are connected to vessels in the pelvis and its ureter is joined to the bladder. Open surgery remains an established approach. Robotic transplantation may be considered for suitable patients in an appropriately equipped programme.
Dr. Sachin’s practice includes kidney transplant surgery, robotic transplantation and complex vascular or urinary tract considerations. The proposed approach should be explained for the recipient’s anatomy and clinical circumstances.
Recovery and the long term
Follow-up monitors kidney function, medicines, infection and rejection. Immunosuppressive treatment and regular blood tests are essential after transplantation. A successful operation does not remove the need for continued medical care.
Risks include bleeding, thrombosis, urinary leakage or narrowing, delayed graft function, rejection and infection. The individual risk and recovery plan are discussed by the transplant team.
Transplant-related urological problems
A consultation may also address ureteric obstruction, anastomotic narrowing or other reconstructive issues after a transplant. The plan depends on graft function, imaging, infection and earlier interventions.
- Bring dialysis and nephrology summaries, transplant records if applicable, and recent tests.
- Ask how the surgical and nephrology teams will coordinate care.
- Clarify follow-up frequency, medicine access and emergency contact arrangements.
- Discuss practical support for both recipient and donor.
Common questions
Does every transplant qualify for a robotic approach?
No. Patient anatomy, vascular findings, donor kidney features and programme factors influence suitability.
Can anti-rejection medicines be stopped when the kidney works well?
They must not be stopped or changed without the transplant team’s instructions. Good function does not mean immune suppression is no longer needed.